Quarterly report pursuant to Section 13 or 15(d)

Statement of Changes in Stockholders??? Equity (Deficit) (Unaudited)

v3.22.2
Statement of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   3,527,850    
Beginning balance at Dec. 31, 2020 $ (4,785) $ 0 $ 11 $ (4,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation, expense 32   32  
Stock issuance upon vesting and exercise of stock options (in shares)   19,318    
Debt discount, share settled debt 1,644   1,644  
Net loss (1,155)     (1,155)
Ending balance (in shares) at Jun. 30, 2021   3,547,168    
Ending balance at Jun. 30, 2021 (4,264) $ 0 1,687 (5,951)
Beginning balance (in shares) at Mar. 31, 2021   3,538,646    
Beginning balance at Mar. 31, 2021 (4,986) $ 0 20 (5,006)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation, expense 23   23  
Stock issuance upon vesting and exercise of stock options (in shares)   8,522    
Debt discount, share settled debt 1,644   1,644  
Net loss (945)     (945)
Ending balance (in shares) at Jun. 30, 2021   3,547,168    
Ending balance at Jun. 30, 2021 (4,264) $ 0 1,687 (5,951)
Beginning balance (in shares) at Dec. 31, 2021   7,809,912    
Beginning balance at Dec. 31, 2021 13,410 $ 1 22,633 (9,224)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation, expense 423   423  
Sale of Common Stock and Warrants (in shares)   136,025    
Sale of Common Stock and Warrants 804   804  
Stock Issued During Period, Value, Stock Options Exercised $ 2   2  
Stock issuance upon vesting and exercise of stock options (in shares) 28,571 28,571    
Stock issuance upon vesting of restricted stock awards (in shares)   7,500    
Net loss $ (5,671)     (5,671)
Ending balance (in shares) at Jun. 30, 2022   7,982,008    
Ending balance at Jun. 30, 2022 8,968 $ 1 23,862 (14,895)
Beginning balance (in shares) at Mar. 31, 2022   7,958,888    
Beginning balance at Mar. 31, 2022 12,227 $ 1 23,596 (11,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation, expense 264   264  
Stock Issued During Period, Value, Stock Options Exercised 2   2  
Stock issuance upon vesting and exercise of stock options (in shares)   19,370    
Stock issuance upon vesting of restricted stock awards (in shares)   3,750    
Net loss (3,525)     (3,525)
Ending balance (in shares) at Jun. 30, 2022   7,982,008    
Ending balance at Jun. 30, 2022 $ 8,968 $ 1 $ 23,862 $ (14,895)